Lisa Seidel
12PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Nov 11, 2024
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.Joseph Tintelnot, Lisa Paschold, Eray Goekkurt
|Aug 21, 2024
A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors.Christoph Schultheiß, Lisa Paschold, Alma Nazlie Mohebiany
|Jul 31, 2024
B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection.Christoph Schultheiß, Edith Willscher, Lisa Paschold
|Feb 02, 2024
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia.Florian Märkl, Christoph Schultheiß, Murtaza Ali
|Jun 16, 2023
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial.Lisa Paschold, Alexander Stein, Benjamin Thiele
|Apr 27, 2023
Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis.Christoph Schultheiß, Silja Steinmann, Edith Willscher
Pageof 2
Frequent Collaborators
11 joint publications
Mascha Binder
9 joint publications
Christoph Schultheiß
5 joint publications
Edith Willscher
2 joint publications
Rebekka Scholz
2 joint publications
Joseph Tintelnot
1 joint publications
Donjete Simnica
1 joint publications
Barbara Seliger
1 joint publications
Cornelia Gottschick
1 joint publications
Lidia Bosurgi
1 joint publications
Daniel Sedding
